Correlation of different markers (p53, EGF-R, c-erbB-2, Ki-67) expression in the diagnostic biopsies and the corresponding resected tumors in non-small cell lung cancer-Reference-Cited by-同舟云学术

Correlation of different markers (p53, EGF-R, c-erbB-2, Ki-67) expression in the diagnostic biopsies and the corresponding resected tumors in non-small cell lung cancer

Published:2004-06 Issue:3 Volume:44 Page:295-301
ISSN:0169-5002
Container-title:Lung Cancer
language:en
Short-container-title:Lung Cancer

Author:

Meert Anne-Pascale,Martin Benoit,Verdebout Jean-Marc,Paesmans Marianne,Berghmans Thierry,Ninane Vincent,Sculier Jean-Paul

Publisher

Elsevier BV

Subject

Cancer Research,Pulmonary and Respiratory Medicine,Oncology

Reference16 articles.

1. Landis SH, Murray T, Bolden S, Wingo PA. Cancer statistics, 1999. CA Cancer J Clin 1999;49(1):8–31, 1.

2. The role of EGF-R expression on the survival of patients with lung cancer: a systematic review of the literature with meta-analysis;Meert;Eur. Resp. J.,2002

3. Role of p53 as a prognostic factor for survival in lung cancer: a systematic review of the literature with a meta-analysis;Steels;Eur. Respir. J.,2001

4. Angiogenesis and molecular biologic substaging in patients with stage I non-small cell lung cancer;Harpole;Ann. Thorac. Surg.,1996

5. Overview of the role of neoadjuvant chemotherapy for early stage non-small cell lung cancer;Depierre;Semin. Oncol.,2001

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Computed tomography-guided lung biopsy for molecular tests: a meta-analysis;Polish Journal of Cardio-Thoracic Surgery;2022

2. Chemotherapy treatment is associated with altered PD-L1 expression in lung cancer patients;Journal of Cancer Research and Clinical Oncology;2018-04-19

3. Establishment of patient-derived tumor xenograft (PDTX) models using samples from CT-guided percutaneous biopsy;Brazilian Journal of Medical and Biological Research;2017

4. In Silico Oncology: Quantification of the In Vivo Antitumor Efficacy of Cisplatin-Based Doublet Therapy in Non-Small Cell Lung Cancer (NSCLC) through a Multiscale Mechanistic Model;PLOS Computational Biology;2016-09-22

5. Neoadjuvant Therapy in Non–Small Cell Lung Cancer;Surgical Oncology Clinics of North America;2016-07